Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project. Reumatismo [Internet]. 2009 Mar. 30 [cited 2025 Sep. 6];61(1):54-6. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2009.54